Related Experiment Video
Updated: Aug 22, 2025

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
Published on: March 1, 2015
Dysphagia for medication in Parkinson's disease
Bendix Labeit1,2, Elijahu Berkovich3, Inga Claus4
1Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany. Bendixruven.Labeit@ukmuenster.de.
Swallowing difficulties, or dysphagia, affect nearly 70% of Parkinson's disease (PD) patients, complicating oral medication intake and potentially leading to motor complications.
Area of Science:
- Neurology
- Gastroenterology
- Pharmacology
Background:
- Dysphagia is a prevalent symptom in Parkinson's disease (PD).
- It is widely assumed that dysphagia complicates oral medication intake in PD patients.
- The direct association between dysphagia for medication and motor complications in PD requires comprehensive investigation.
Purpose of the Study:
- To investigate dysphagia specifically related to medication intake in Parkinson's disease patients.
- To explore the association between dysphagia for medication and the occurrence of motor complications in PD.
- To introduce and validate a classification system for dysphagia in PD.
Main Methods:
- Retrospective analysis to develop a dysphagia classification system based on swallowing efficiency and safety.
- Prospective study involving 66 PD patients undergoing flexible endoscopic evaluation of swallowing (FEES).
- FEES included swallowing of tablets and capsules of various sizes; assessment using MDS-UPDRS-part-IV.
Main Results:
- Dysphagia for medication was identified in nearly 70% of PD patients.
- Dysphagia for medication significantly predicted motor complications (MDS-UPDRS-part-IV) in a linear regression model.
- Capsules were swallowed more efficiently than tablets, regardless of size; MDS-UPDRS score ≥1 is an optimal predictor.
Conclusions:
- Impaired swallowing of oral medication is common in Parkinson's disease.
- Dysphagia for medication is a significant predictor of motor complications in PD.
- Targeted interventions for medication-related dysphagia may help manage motor complications in PD.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Taste Buds and Receptors
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

